Buy Marksans Pharma, NOCIL: Nooresh Merani

Nooresh Merani of Asian Market Securities told CNBC-TV18, "NOCIL gave a 52 week high and a one year breakout above Rs 53-55 level, it went up to Rs 62-63 and has retraced back to those levels, so that could be a good entry point with a stop loss at Rs 50 and a target price of Rs 70 in the medium-term." "Kopran gave 52-week high as well as a range breakout above Rs 72 after 6-12 months of consolidation. After making a move to Rs 80-84 the stock has retraced back to the levels of Rs 72-74, so it could be a risk reward at this point with a stop loss at Rs 68 and a target price of Rs 90," he said. "Marksans Pharma has been in a strong uptrend for the last few months. In the near term it has a lot of support around Rs 94-96, so it is a risk reward buy at those levels with a stop loss at Rs 92 and a target price of Rs 110."